These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 7927504)
1. The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA. Nikolova EB; Tomana M; Russell MW Immunology; 1994 Jun; 82(2):321-7. PubMed ID: 7927504 [TBL] [Abstract][Full Text] [Related]
2. All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone. Nikolova EB; Tomana M; Russell MW Scand J Immunol; 1994 Mar; 39(3):275-80. PubMed ID: 8128187 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation. Russell MW; Reinholdt J; Kilian M Eur J Immunol; 1989 Dec; 19(12):2243-9. PubMed ID: 2606139 [TBL] [Abstract][Full Text] [Related]
4. Resistance of normal serum IgA and secretory IgA to bacterial IgA proteases: evidence for the presence of enzyme-neutralizing antibodies in both serum and secretory IgA, and also in serum IgG. Kobayashi K; Fujiyama Y; Hagiwara K; Kondoh H Microbiol Immunol; 1987; 31(11):1097-106. PubMed ID: 3127662 [TBL] [Abstract][Full Text] [Related]
5. Activation of complement by human serum IgA, secretory IgA and IgA1 fragments. Hiemstra PS; Biewenga J; Gorter A; Stuurman ME; Faber A; van Es LA; Daha MR Mol Immunol; 1988 Jun; 25(6):527-33. PubMed ID: 3173354 [TBL] [Abstract][Full Text] [Related]
6. Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD). Boackle RJ; Nguyen QL; Leite RS; Yang X; Vesely J Mol Immunol; 2006 Feb; 43(3):236-45. PubMed ID: 16199260 [TBL] [Abstract][Full Text] [Related]
7. Differential susceptibility of human IgA immunoglobulins to streptococcal IgA protease. Plaut AG; Wistar R; Capra JD J Clin Invest; 1974 Dec; 54(6):1295-300. PubMed ID: 4436434 [TBL] [Abstract][Full Text] [Related]
8. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes. Zhang W; Lachmann PJ Immunology; 1994 Jan; 81(1):137-41. PubMed ID: 8132210 [TBL] [Abstract][Full Text] [Related]
9. Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA. Russell MW; Mansa B Scand J Immunol; 1989 Aug; 30(2):175-83. PubMed ID: 2762767 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the binding of secretory component to immunoglobulin A (IgA) in human colostral S-IgA1 and S-IgA2. Almogren A; Senior BW; Kerr MA Immunology; 2007 Feb; 120(2):273-80. PubMed ID: 17156102 [TBL] [Abstract][Full Text] [Related]
11. IgA1 proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: comparative immunochemical studies. Kilian M; Mestecky J; Kulhavy R; Tomana M; Butler WT J Immunol; 1980 Jun; 124(6):2596-600. PubMed ID: 6768797 [TBL] [Abstract][Full Text] [Related]
12. Actions of three clostridial IgA proteases on distinct forms of immunoglobulin A molecules. Hashim OH; Hassan H Immunology; 1991 Jun; 73(2):235-8. PubMed ID: 2071167 [TBL] [Abstract][Full Text] [Related]
13. The specificity of the human neutrophil IgA receptor (Fc alpha R) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2. Stewart WW; Kerr MA Immunology; 1990 Nov; 71(3):328-34. PubMed ID: 2269470 [TBL] [Abstract][Full Text] [Related]
15. A human T-cell receptor recognizes 'O'-linked sugars from the hinge region of human IgA1 and IgD. Rudd PM; Fortune F; Patel T; Parekh RB; Dwek RA; Lehner T Immunology; 1994 Sep; 83(1):99-106. PubMed ID: 7821975 [TBL] [Abstract][Full Text] [Related]
16. Normal human sera contain antibodies directed at Fab of IgA. Jackson S; Montgomery RI; Mestecky J; Czerkinsky C J Immunol; 1987 Apr; 138(7):2244-8. PubMed ID: 3494062 [TBL] [Abstract][Full Text] [Related]
17. IgA-mediated inhibition of human leucocyte function by interference with Fc gamma and C3b receptors. Saito K; Kato C; Katsuragi H; Komatsuzaki A Immunology; 1991 Sep; 74(1):99-106. PubMed ID: 1834550 [TBL] [Abstract][Full Text] [Related]
18. Degradation of human secretory IgA1 and IgA2 by Entamoeba histolytica surface-associated proteolytic activity. Garcia-Nieto RM; Rico-Mata R; Arias-Negrete S; Avila EE Parasitol Int; 2008 Dec; 57(4):417-23. PubMed ID: 18571975 [TBL] [Abstract][Full Text] [Related]
19. Molecular aspects of immunoglobulin A1 degradation by oral streptococci. Reinholdt J; Tomana M; Mortensen SB; Kilian M Infect Immun; 1990 May; 58(5):1186-94. PubMed ID: 2182537 [TBL] [Abstract][Full Text] [Related]
20. The site of cleavage in human alpha chains of IgA1 and IgA2:A2m(1) allotype paraproteins by the clostridial IGA protease. Fujiyama Y; Iwaki M; Hodohara K; Hosoda S; Kobayashi K Mol Immunol; 1986 Feb; 23(2):147-50. PubMed ID: 3084949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]